Piramal Pharma Solutions expands peptide API capacity with a new Class 5 spray‑drying unit in Turbhe, India
Executive summary: Piramal Pharma Solutions commissioned a new Class 5 containment spray‑drying unit at its peptide API manufacturing site in Turbhe, India. The expansion increases the company's capacity to produce potent peptide active pharmaceutical ingredients under stringent containment, supporting growing demand for peptide‑based drugs.
Who is involved: Piramal Pharma Solutions (manufacturing division), located at Turbhe, India.
Likely next: The unit will undergo validation and ramp‑up production, potentially leading to increased peptide API supply for contract manufacturing customers.
Piramal Pharma Solutions has brought online a new spray‑drying unit featuring Class 5 containment at its peptide‑focused facility in Turbhe, India. The unit includes dedicated air‑handling systems, underscoring the company’s investment in high‑potency peptide manufacturing. This expansion responds to rising demand for peptide‑based active pharmaceutical ingredients while enhancing the site’s containment capabilities.
Timeline
- — Piramal Pharma Solutions agrandit son site de production d'API peptidiques avec l'ajout d'une unité de séchage par atomisation de pointe (PR Newswire)